Schrodinger began laying off the clinical team today. They’re also ending “independent” clinical development, which really closes the door on their entire clinical pipeline - especially since these poor performing assets have failed to attract any partner interest even after years of development. The Chief Medical Officer is also leaving.
These actions highlight the failure of Schrodinger’s executive leadership and board of directors. Their inability to deliver any assets that can succeed in the clinic is a direct reflection their incompetence, inexperience and ineffective leadership. There’s a repeated pattern of poor judgment, weak decision-making, and avoidance of accountability. It’s amazing that, despite this utter abysmal performance, the C-suite and BoD has not been held accountable. It’s time to clean house and find competent replacements that can deliver results.